Last reviewed · How we verify
NCT03402399: MRMF01
Defining the Molecular Risk in Israeli Patients With Secondary Compared to Primary Myelofibrosis
NA trial testing Molecular analysis in Myelofibrosis, Primary in 222 participants. Status unknown.
9 December 2019
Quick facts
| Lead sponsor | Assaf-Harofeh Medical Center |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 222 |
| Start date | 10 December 2017 |
| Primary completion | 9 December 2019 |
| Estimated completion | 9 December 2020 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Molecular analysis
Conditions studied
- Myelofibrosis, Primary — all drugs for Myelofibrosis, Primary →
- Myelofibrosis, Post PV — all drugs for Myelofibrosis, Post PV →
- Myelofibrosis, Post ET — all drugs for Myelofibrosis, Post ET →
Sponsor
Assaf-Harofeh Medical Center
Who can join
18 and older, any sex, with Myelofibrosis, Primary or Myelofibrosis, Post PV. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to determine the rate of HMR mutations in PMF and secondary MF (post PV/ET) subjects, and correlate the rate of mutations with clinical features as known prognostic scores.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03402399
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Molecular analysis
Trials testing the same drug.
- NCT06424379 — BCL6-rearrangements Implications in Non-Hodgkin Lymphomas. · active not recruiting
- NCT04172870 — Evaluation of Inflammatory Markers and Periodontal Viruses on Periodontitis Patients With CAD · unknown
- NCT03089268 — Molecular and Histological Characteristics of Serrated Lesions of the Colon · active not recruiting
Other recruiting trials for Myelofibrosis, Primary
Currently open trials in the same condition.
- NCT07362225 — MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myel · recruiting
Other Assaf-Harofeh Medical Center trials
Trials by the same sponsor.
- NCT07334639 — Metabolic Changes Associated With Weight Gain After Treatment of Achalasia · not yet recruiting
- NCT07276334 — Same Day Discharge Vs. Hospitalization for Operative Fixation of Distal Radius Fractures · NA · enrolling by invitation
- NCT07231900 — Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients · Phase 2, PHASE3 · not yet recruiting
- NCT07252180 — Comparing Two Different Methods of Ablation of Inlet Patches (APC vs RFA) · NA · active not recruiting
- NCT04664790 — Hyperbaric Oxygen Therapy Compared to Cognitive Training in FASD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03402399 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assaf-Harofeh Medical Center
- Last refreshed: 5 July 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03402399.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing